Oncology Nursing Support for Safe and Effective Use of Eribulin in Metastatic Breast Cancer
[Clin Med Insights Oncol] A review of five case studies of women with MBC who were managed successfully with eribulin mesylate in late lines of therapy after at least two chemotherapeutic regimens for advanced breast cancer that included both an anthracycline and a taxane in either the adjuvant or metastatic setting.
